Dernières nouvelles pour Allakos (NASDAQ:ALLK) Stock

Allakos

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation. Its portfolio consists of antibodies that target receptors, particularly Siglec-6, Siglec-8 and other anti-Siglec antibodies, including some antibodies in preclinical development.

Allakos Inc

Allkem Ltd

Central Pacific Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPF#NYSE">CPF</a>) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.63 by 3.17 percent. This is a 35.42 percent increase over earnings of $0.48 per share from the same period last year. The company reported quarterly sales of $57.70 million which beat the analyst consensus estimate of $57.22 million by 0.85 percent. This is a 14.97 percent increase over sales of $50.19 million the same period last year.

Earnings

Earnings Beats

News

Central Pacific Financial Q1 Adj. EPS $0.65 Beats $0.63 Estimate, Sales $57.70M Beat $57.22M Estimate

Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) is looking for Q2 Adj EPS of $0.71-$0.73 vs $0.71 analyst estimate..

Guidance

Boston Scientific Sees Q2 Adj EPS $0.71-$0.73 vs $0.71 Est and estimates net sales growth for the second quarter of 2025 to be in a range of approximately 17.5 to 19.5 percent on a reported basis versus the prior year period

Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) is looking for Q2 GAAP EPS of $0.45-$0.47 vs $0.48 analyst estimate..

Boston Scientific Sees Q2 GAAP EPS $0.45-$0.47 vs $0.48 Est

Telsey Advisory Group analyst Joseph Feldman maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Outperform and lowers the price target from $275 to $235.

Price Target

Analyst Ratings

AMZN

Telsey Advisory Group Maintains Outperform on Amazon.com, Lowers Price Target to $235

Walgreens Has Teamed Up With Guild To Launch PharmStart, A First-of-its-kind, Fully Funded Online Education Program Designed To Help Eligible Team Members Meet The Prerequisite Requirements For Pharmacy School

Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) raises FY2025 Adj EPS guidance from $2.80-$2.87 to $2.87-$2.94 vs $2.86 analyst estimate..

Boston Scientific Raises FY2025 Adj EPS Guidance from $2.80-$2.87 to $2.87-$2.94 vs $2.86 Est and estimate net sales growth for the full year 2025 to be approximately 15 to 17 percent versus the prior year period

Travel+Leisure (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNL#NYSE">TNL</a>) .

Travel+Leisure expects FY 2025 Adjusted EBITDA of $955 million to $985 million

AT&T Sees FY2025 Adj EPS Guidance of $1.97-$2.07 vs $2.04 Est

Travel+Leisure expects Q2 2025 Adjusted EBITDA of $245 million to $255 million

Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) affirms FY2025 GAAP EPS guidance from $1.86-$1.93 to $1.86-$1.93 vs $1.96 analyst estimate..

Boston Scientific Affirms FY2025 GAAP EPS Guidance of $1.86-$1.93 vs $1.96 Est

AT&T Q1 Adj. EPS $0.51 Beats $0.49 Estimate, Sales $30.63B Beat $30.35B Estimate

Prosperity Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PB#NYSE">PB</a>) reported quarterly earnings of $1.37 per share which beat the analyst consensus estimate of $1.36 by 0.74 percent. This is a 16.1 percent increase over earnings of $1.18 per share from the same period last year. The company reported quarterly sales of $306.68 million which missed the analyst consensus estimate of $308.17 million by 0.48 percent. This is a 10.67 percent increase over sales of $277.11 million the same period last year.

Earnings Misses

Prosperity Bancshares Q1 Adj. EPS $1.37 Beats $1.36 Estimate, Sales $306.68M Miss $308.17M Estimate

Westinghouse Air Brake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAB#NYSE">WAB</a>) raises FY2025 Adj EPS guidance from $8.35-$8.75 to $8.35-$8.95 vs $8.54 analyst estimate. Affirms FY2025 sales outlook from $10.72 billion-$11.03 billion to $10.72 billion-$11.03 billion vs $10.95 billion estimate.

Westinghouse Air Brake Raises FY2025 Adj EPS Guidance from $8.35-$8.75 to $8.35-$8.95 vs $8.54 Est; Affirms FY2025 Sales Guidance of $10.72B-$11.03B vs $10.95B Est

GPUS

Hyperscale Data Announced That Its Indirectly Wholly Owned Subsidiary BitNile.Com, Inc. Will Develop And Launch Its Own Coin, Nile Coin, On The Solana Blockchain Platform

Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0.67 by 11.94 percent. This is a 33.93 percent increase over earnings of $0.56 per share from the same period last year. The company reported quarterly sales of $4.66 billion which beat the analyst consensus estimate of $4.57 billion by 1.99 percent. This is a 20.93 percent increase over sales of $3.86 billion the same period last year.

Boston Scientific Q1 Adj. EPS $0.75 Beats $0.67 Estimate, Sales $4.66B Beat $4.57B Estimate

Travel+Leisure (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNL#NYSE">TNL</a>) reported quarterly earnings of $1.11 per share which missed the analyst consensus estimate of $1.12 by 0.89 percent. This is a 14.43 percent increase over earnings of $0.97 per share from the same period last year. The company reported quarterly sales of $934.00 million which beat the analyst consensus estimate of $933.67 million by 0.04 percent. This is a 1.97 percent increase over sales of $916.00 million the same period last year.

Travel+Leisure Q1 Adj. EPS $1.11 Misses $1.12 Estimate, Sales $934.00M Beat $933.67M Estimate

Westinghouse Air Brake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAB#NYSE">WAB</a>) reported quarterly earnings of $2.28 per share which beat the analyst consensus estimate of $2.03 by 12.32 percent. This is a 20.63 percent increase over earnings of $1.89 per share from the same period last year. The company reported quarterly sales of $2.61 billion which met the analyst consensus estimate. This is a 4.53 percent increase over sales of $2.50 billion the same period last year.

Westinghouse Air Brake Q1 Adj. EPS $2.28 Beats $2.03 Estimate, Sales $2.61B Inline

GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) affirms FY2025 sales outlook from $36.00 billion-$37.00 billion to $36.00 billion-$37.00 billion vs $36.73 billion estimate.

GE Vernova Affirms FY2025 Sales Guidance of $36.00B-$37.00B vs $36.73B Est

Telsey Advisory Group analyst Dana Telsey maintains Oxford Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXM#NYSE">OXM</a>) with a Market Perform and lowers the price target from $64 to $52.

Telsey Advisory Group Maintains Market Perform on Oxford Industries, Lowers Price Target to $52

Legendary investor and Chairman of Berkshire Hathaway Inc., (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) Warren Buffett, has been consistently defending the Federal Reserve's independence over the past twenty years.
From live interviews to town halls, Buffett has frequently emphasized the importance of protecting the Fed from political meddling.
At a time when President Donald Trump is <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44875406/hell-be-out-if-i-ask-him-can-trumps-threat-to-oust-powell-shake-the-fed">making headlines</a> for his repeated jabs at Fed Chair Jerome Powell, and going back and forth on his intention to fire him, Buffett's views merit attention.
Throughout the years, his stance has been steady: Interfering with the Fed's autonomy <a href="https://www.benzinga.com/news/25/04/44882256/trumps-threat-to-fire-powell-could-shake-us-financial-markets">puts the economy at the risk </a>of long-term damage.
What He's Said: In a November 2009 CNBC <a href="https://www.cnbc.com/2009/11/20/warren-buffett-to-cnbc-curbing-feds-independence-could-lead-to-mischief.html">interview</a>, Buffett said, "We do not want to fool around with the independence of the Fed." He continued, warning that any attempts to weaken the central bank's authority could "lead to a lot of mischief."
That was not a one-off statement. In another conversation about fiscal policy, Buffett said: "I am 100% for the independence of the Fed… if you have a central bank that is bowing to the will of Congress either directly or indirectly through some of various mechanisms, it would be a disaster."
Buffett has highlighted that an independent Fed is vital not just for stability, but for managing crises: "Ben Bernanke was essential to keeping us from going into the abyss," he said, lauding the former Fed Chair's response to the 2008 financial crisis.
In a similar vein, he credited Paul Volcker as "essential to this country coming out of that 1981–82 period."
See Also: <a href="https://www.benzinga.com/news/25/04/44935195/elizabeth-warren-says-if-trump-illegally-fires-fed-chair-powell-hell-crash-our-markets-cause-more-economic-pain-to-american-families">Elizabeth Warren Says, &#8216;If Trump Illegally Fires Fed Chair Powell, He&#8217;ll Crash Our Markets, Cause More Economic Pain To American Families&#8217;</a>
Why It Matters: To Buffett, the Fed's role is uniquely challenging. During a 2008 appearance on Squawk Box, he said: "They've got a tough problem with these dual goals of essentially stimulating growth and, at the same time, containing inflation. They are in direct conflict."
He added, "There are no obvious answers. There are trade-offs… But I admire the people that take on the job."
Buffett has also pushed back against the perception that the Fed has limitless power. In the same interview, he said: "I think they are thought to have more power than they really do have. Ben Bernanke does not have a magic wand."
U.S. stock futures moved upward Tuesday night after President Donald Trump told reporters from the Oval Office that he has <a href="https://www.benzinga.com/25/04/44940900/us-futures-dollar-jump-amid-trumps-latest-comments-on-fed-nikkei-rebounds-to-three-week-high">&#8220;no intention&#8221; of firing Federal Reserve Chair Jerome Powell</a>, adding, &#8220;I never did.&#8221; S&amp;P 500 futures rose 1.54% to 5,396, while Nasdaq futures climbed 1.87% to 18,728. Japan's Nikkei 225 also gained 1.89%, reaching 34,869.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44918830/jim-cramer-takes-a-dig-at-trumps-criticism-of-powell-you-would-actually-buy-this-rally-if-trump-hadnt-criticized-the-fed-chair">Jim Cramer Takes A Dig At Trump&#8217;s Criticism Of Powell: &#8216;You Would Actually Buy This Rally&#8217; If Trump Hadn&#8217;t Criticized The Fed Chair</a></li>
</ul>
Photo courtesy: mark reinstein / Shutterstock.com

Comments

Allakos

Actualités

Dernières nouvelles pour Allakos (NASDAQ:ALLK) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL